Testing a Home-Based Support Pathway for People Newly Diagnosed With Parkinson's Disease
Tests a home-based care pathway in adults newly diagnosed with Parkinson's disease.
Key facts
- Who runs it
- University Hospital, Toulouse
- Where
- Toulouse, FranceSee the site
- Trial code
- Registry title
- Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study
- Status
- Not yet recruiting
- People taking part
- 100 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 31 Mar 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Patient questionnaires
- Caregiver questionnaires
- Record updated
- 11 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults whose Parkinson's disease was diagnosed less than 1 month ago, and for their main caregivers. It tests a home-based care pathway after the diagnosis.
- Age
- Over 18 years of age
- Sex
- All sexes can join
- Disease stage
- Newly diagnosed Parkinson's disease (less than 1 month)
Main reasons for not taking part
- Patients living in an institution
- Patients living outside the area covered by the specialized neurodegenerative disease teams
- Caregivers who do not wish to take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- For patients:
- Patients with newly diagnosed Parkinson's disease (< 1 month)
- Over 18 years of age; For caregivers (if the caregiver does not wish to participate, the patient can be included):
- Primary caregiver of a patient with newly diagnosed Parkinson's disease (< 1 month)
- Over 18 years of age
Who cannot take part
- Residents of an area not covered by the intervention zone of specialized neurodegenerative disease teams; For caregivers
- For patients
- Institutionalized patients
- Participants who do not wish to participate
Where in France
- Service de Neurologie Cognitive, Comportementale et Mouvement anormaux CHU de Toulouse, Hôpital Pierre Paul Riquet, 31059 Toulouse Cedex 9Toulouse, FranceContact: Fabienne ORY MAGNE, MDNo longer taking part
About the trial
What the trial wants to find out
Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide, with a prevalence expected to double by 2040. The diagnosis of PD is often a shock for patients and their families, due to a lack of preparation and adequate support. Progress has been made with the establishment of Parkinson's disease expert centers (PDECs) and better-structured care pathways, but limitations remain. The needs of patients, their caregivers, and neurologists at the time of diagnosis were studied, leading to the development of a flexible, adaptable, and multidisciplinary home-based care pathway. This pathway includes multimodal communication tools (booklet and website) and can also be used by caregivers. The aim is to evaluate this pathway at the departmental level and its ability to prevent the medical, social, and psychosocial risks that complicate the care of patients newly diagnosed with PD. Thus, offering the patient, their caregiver and their neurologist a truly flexible and local care pathway built according to their needs, from the moment the disease is announced, could allow for better acceptance of the disease, an improvement in quality of life, the adoption of beneficial practices as well as a patient-caregiver therapeutic alliance with good adherence to drug and non-drug therapies.
The 2 groups in the trial
- patients benefiting from a care pathwayTreatment being tested
patients benefiting from a flexible and local care pathway
Treatment: Patient questionnaires
- caregivers of Parkinson's disease patientsOther group
Treatment: Caregiver questionnaires
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prevention of Medical, Social, and Psychosocial Risks Following a Parkinson's Disease Diagnosis: A Pilot Study
- Plain-language title
- Testing a Home-Based Support Pathway for People Newly Diagnosed With Parkinson's DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 11 May 2026